What's breaking now, across thousands of outlets.
About 26 months after failing two Phase 3 trials, an epilepsy treatment candidate is getting plucked off biopharma's shelves and will be given a new chance at life. Life sciences investment firm Perceptive Advisors is ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
There are new rules for those who don’t have a permanent residence permit or citizenship and need to go to a public hospital.
Lucknow, August 13: Ensuring that girls' education is not disrupted due to a biological process and that schools become safe, respectful and sensitive spaces for them, the Yogi Government is…
The Maharashtra Food and Drug Administration (FDA) has suspended the licences of multiple food establishments, including four Domino’s Pizza outlets, as part of an intensified food safety enforcement…
(MedPage Today) -- Half of participants in a new, increasingly popular fitness competition called HYROX said they had sustained an injury during training for it during the previous year, an…
European regulators on Thursday detailed their skepticism of data behind Amgen's rare disease drug Tavneos, explaining a decision last week to pull the drug from the market there. In new documents ...
A compound produced by bacteria in many people's digestive tracts increases the risk of developing Alzheimer's disease and speeds cognitive decline in dementia patients, making it a potential target…
